IFF Earnings Call Highlights Margin Gains, Cautious Outlook

International Flavors & Fragrances ((IFF)) has held its Q1 earnings call. Read on for the main highlights of the call.

International Flavors & Fragrances opened 2026 on a confident note, delivering broad-based volume growth, expanding margins and markedly stronger cash generation while trimming leverage. Management struck a generally upbeat tone around operational momentum and portfolio reshaping, even as they highlighted geopolitical risks, rising energy and logistics costs, and near-term pressure on margins in the coming quarter.

Revenue and Top-Line Growth

IFF reported first-quarter revenue above $2.7 billion, translating into 3% year-over-year sales growth on a currency-neutral basis. Growth was volume-led across all businesses rather than price-driven, signaling healthier underlying demand and suggesting that the company is gaining share in key markets rather than relying on inflationary pricing.

Adjusted EBITDA and Margin Expansion

Adjusted operating EBITDA climbed 8% year-over-year to $568 million, with margins expanding 110 basis points to 20.7%, the best level since 2022. Management credited disciplined cost control, mix improvement and productivity gains for the step-up in profitability, framing the stronger margin as evidence that prior restructuring and integration work is now paying off.

Taste Segment Profitability Surge

The Taste division posted 2% sales growth to $656 million but delivered a much stronger 18% increase in adjusted operating EBITDA to $153 million. Higher volumes, favorable net pricing and ongoing productivity initiatives combined to lift margins, reinforcing Taste as a key earnings driver and demonstrating the leverage that exists once volumes stabilize.

Food Ingredients Delivers Volume-Led Growth

Food Ingredients generated 3% sales growth to $839 million with volumes up about 5%, the strongest volume performance in several years. Adjusted operating EBITDA grew 12% to $114 million, underscoring improving profitability even as the business is marketed for sale, and highlighting its attractiveness to potential buyers given the clear operating momentum.

Health & Biosciences Momentum

Health & Biosciences recorded $595 million in revenue, up 5% year-over-year entirely driven by volume increases. Adjusted operating EBITDA rose 7% to $153 million, with Animal Nutrition and Food Biosciences leading the way, reinforcing this segment as a structurally growing platform supported by demand for specialty and sustainability-focused applications.

Cash Flow Strength and Deleveraging

Cash flow from operations rose to $257 million, improving by $130 million from the prior year, while free cash flow turned positive at $92 million, up $144 million. Gross debt fell to $5.85 billion, more than $3 billion lower than a year ago, bringing net debt to credit-adjusted EBITDA to about 2.5 times and significantly enhancing financial flexibility.

Capital Returns and Financial Discipline

IFF returned $102 million to shareholders via dividends and $35 million through its dilution-offset share repurchase program in the quarter. Management emphasized continued discipline in capital allocation, reiterating a leverage target around 2.5 times net debt to EBITDA and signaling that balance sheet strength remains a priority alongside steady shareholder returns.

Portfolio Actions and Latin America Investments

The company completed the divestiture of its commodity soy crush, concentrates and lecithin business for $110 million, narrowing its focus on higher-value offerings. The sale process for Food Ingredients is advancing with solid buyer interest, while new fermentation and innovation facilities in Argentina and Brazil are intended to capture growth in Latin America and deepen local customer partnerships.

Scent Segment and Fragrance Ingredients Pressure

The Scent business posted modest 1% sales growth to $651 million, but adjusted operating EBITDA slipped 2% to $148 million as favorable volumes and productivity could not offset unfavorable price-to-input cost dynamics. The commodity portion of Fragrance Ingredients was notably weak amid market softness and aggressive price competition, especially from lower-cost producers in India and China, creating a drag on segment margins.

Middle East Conflict and Q2 Softness

Management flagged ongoing macro uncertainty tied to the Middle East conflict, which is hurting Fine Fragrance through both demand disruption and packaging and supply-chain challenges. As a result, the company expects second-quarter EBITDA dollars to decline versus the first quarter, reflecting lower volumes, weaker mix and adverse price-to-input cost relationships before pricing measures fully catch up.

Inflation in Energy and Logistics

Inflationary pressure in energy and logistics has picked up sharply compared with 2025, with some categories experiencing double-digit increases. IFF anticipates raw material inflation to build later in 2026 and is deploying surcharges and staged pricing actions to offset these costs, although management acknowledged a lag before these measures are fully reflected in margins.

Strategic Shift in Commodity Fragrance Ingredients

Facing intense competition from low-cost suppliers in India and China in the commodity slice of Fragrance Ingredients, the company plans to de-emphasize external commodity sales. While this strategy should eventually improve the quality of earnings, it creates a near-term revenue and profit headwind for that subbusiness as IFF prioritizes higher-value, more defensible specialties.

Pricing Phasing and Margin Timing Risks

New surcharges tied to logistics and energy are being rolled out but will only gradually feed into the P&L over the coming quarters. Management warned that raw-material pass-throughs can take 12 to 18 months, meaning the near term, especially the second quarter, could see margin compression as input costs rise faster than the company can fully recover them through pricing.

Free Cash Flow Outlook Uncertainty

IFF signaled confidence in delivering a meaningful improvement in free cash flow for 2026 but declined to quantify a full-year target until it has better visibility on cash proceeds from the planned Food Ingredients divestiture. This cautious stance leaves some short-term uncertainty around cash conversion even as the company points to a clearly improving underlying cash and leverage profile.

Guidance and Forward-Looking Outlook

The company reaffirmed 2026 guidance for sales between $10.5 billion and $10.8 billion, implying 1% to 4% growth, and adjusted operating EBITDA of $2.05 billion to $2.15 billion, or 3% to 8% growth, with foreign exchange expected to add about one percentage point to sales. Management’s outlook embeds a softer second quarter due to conflict-related and inflationary pressures but assumes that pricing actions, cost discipline and portfolio moves will support growth and margin resilience over the balance of the year.

IFF’s latest earnings call painted a picture of a business regaining operational traction, expanding margins and rapidly repairing its balance sheet despite geopolitical and cost headwinds. For investors, the combination of reaffirmed full-year guidance, improving cash generation and strategic portfolio streamlining offers a constructive medium-term story, even as near-term earnings volatility remains in focus.